Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Regulatory T cells are essential for normal and improved wound healing in mice.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

New treatments for lupus show promise, but more research is needed, especially for children.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Certain drugs may cause vitiligo, so patients should be monitored.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Targeting regulatory T cells may help treat age-related diseases.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

More precise, personalized therapies are needed for autoimmune diseases.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.